Cargando…
Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia
BACKGROUND: To test and compare in a masked fashion the efficacy of using a parasympathomimetic drug (3% carbachol) and an alpha-2 agonist (0.2% brimonidine) in both combined and separate forms to create optically beneficial miosis to pharmacologically improve vision in presbyopia. METHODS: A prospe...
Autores principales: | Abdelkader, Almamoun, Kaufman, Herbert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139101/ https://www.ncbi.nlm.nih.gov/pubmed/27981057 http://dx.doi.org/10.1186/s40662-016-0065-3 |
Ejemplares similares
-
Fluorimetric Quantification of Brimonidine Tartrate in Eye Drops
por: Sunitha, G., et al.
Publicado: (2013) -
Mechanisms of carbachol oscillations
por: Netoff, Theoden I, et al.
Publicado: (2007) -
Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
por: Tanihara, Hidenobu, et al.
Publicado: (2023) -
Presbyopia Treatment With Eye Drops: An Eight Year Retrospective Study
por: Benozzi, Giovanna, et al.
Publicado: (2020) -
Respiratuvar depression after accidental nasal ingestion of brimonidine eye drops in infant
por: Gunes, Ali, et al.
Publicado: (2016)